Please check your internet connection and try again.
## Iv Dexamethasone
### Overview
Dexamethasone is a potent synthetic corticosteroid with anti-inflammatory and immunosuppressive effects. It is available as an intravenous formulation.
### Primary Indications
* Allergic states
* Rheumatic disorders
* Dermatologic diseases
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic disorders
* Neoplastic diseases (adjunct therapy)
* Nervous system
* Ophthalmic diseases
* Renal diseases
* Respiratory diseases
* Edematous states
* Tuberculous meningitis (with appropriate antituberculous agents)
* Trichinosis with neurologic or myocardial involvement
### Adult Dosing
Dosing is highly variable and depends on the specific condition and severity. Doses can range from 0.5 mg to 9 mg daily, divided into 1-4 doses. For acute, life-threatening situations, higher doses may be utilized. Specific dosing for indications like septic shock or cerebral edema will follow established protocols.
### Pediatric Dosing
Dosing in children is generally lower than in adults and is often based on weight, body surface area, or severity of illness. Specific indications like croup or infantile spasms have established pediatric dosing regimens that should be consulted. General dosing may range from 0.08 mg/kg/day to 0.3 mg/kg/day, divided every 6-12 hours.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is typically required, but caution is advised as corticosteroids can exacerbate underlying renal conditions.
* **Hepatic Impairment:** Dexamethasone is metabolized in the liver. Severe hepatic impairment may require dose reduction or closer monitoring.
### Contraindications
* Systemic fungal infections
* Known hypersensitivity to dexamethasone or other corticosteroids.
### Adverse Effects
Common adverse effects include hyperglycemia, increased susceptibility to infection, fluid and electrolyte disturbances (hypokalemia, sodium retention), psychiatric disturbances (mood changes, insomnia), adrenal suppression, peptic ulceration, growth suppression in children, osteoporosis, myopathy, and Cushingoid effects with prolonged use.
### Key Drug Interactions
* **CYP3A4 Inducers (e.g., phenytoin, rifampin, efavirenz):** May decrease dexamethasone efficacy.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase dexamethasone levels.
* **Diuretics (e.g., thiazides, loop diuretics):** Increased risk of hypokalemia.
* **Warfarin:** May alter anticoagulant effect.
* **Vaccines:** Decreased antibody response; live vaccines are contraindicated.
### Monitoring
* Blood glucose levels
* Electrolytes (potassium, sodium)
* Signs of infection
* Adrenal function (especially upon withdrawal)
* Blood pressure
* Bone mineral density with long-term therapy
* Ophthalmic examinations with long-term therapy
### Clinical Pearls
* Administer intravenously or intramuscularly. Can also be given intra-articularly or intrathecally in specific situations.
* Taper dose gradually when discontinuing to prevent adrenal insufficiency.
* Consider gastric protection (e.g., proton pump inhibitor) in patients at risk for peptic ulcer disease.
* Educate patients about signs of infection and hyperglycemia.
***
*Disclaimer: This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and relevant institutional protocols for definitive dosing and safety guidelines before administering any medication.*
